EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology

Elena A Cherkasova, Long Chen, Richard W Childs

Frontiers in Cellular and Infection Microbiology · 06.02.2024 · 14

DOI: 10.3389/fcimb.2024.1358470 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.02.2024. Verfasst von Elena A Cherkasova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Transplantation Immunotherapy, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcription of distinct loci of human endogenous retroviruses (HERVs) and in some cases, translation of these transcripts have been consistently observed in many types of cancer. It is still debated whether HERV activation serves as a trigger for carcinogenesis or rather occurs as a consequence of epigenetic alterations and other molecular sequelae that characterize cellular transformation. Here we review the known molecular and epigenetic mechanisms of HERV activation in cancer cells as well as its potential contribution to carcinogenesis. Further, we describe the use of HERV expression in cancer diagnostic and characterize the potential of HERV-derived antigens to serve as novel targets for cancer immunotherapy. We believe this review, which summarizes both what is known as well as unknown in this rapidly developing field, will boost interest in research on the therapeutic potential of targeting HERV elements in tumors and the impact of HERV activation in oncogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endogenous RetrovirusesNeoplasmsHumansTranslational Research, BiomedicalCarcinogenesisEpigenesis, Genetic

Stichwörter der Autor:innen

HERV expressioncancer antigenscarcinogenesiscellular immunotherapyepigenetics

Autor:innen und Institutionen

  • Laboratory of Transplantation Immunotherapy, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

Zitieren

APA

Cherkasova, E. A., Chen, L., & Childs, R. W. (2024). Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1358470

Vancouver

Cherkasova EA, Chen L, Childs RW. Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1358470

BibTeX
@article{Cherkasova2024,
  author = {Cherkasova, Elena A and Chen, Long and Childs, Richard W},
  title = {Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1358470}
}
Kostenlos starten →